EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patch Testing in Individuals With Diabetes Using Medical Devices. Part 2—Contact Allergy to Medical Device Allergens and New Patch Test Recommendations

Josefin Ulriksdotter iD, Martin Mowitz iD, Thanisorn Sukakul, Magnus Bruze iD, Nils Hamnerius iD, Cecilia Svedman

Contact Dermatitis · 2026-08 · 95 (2) · 169-181

DOI: 10.1111/cod.70149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contact Dermatitis, online erschienen am 05.04.2026. Verfasst von Josefin Ulriksdotter und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact, Patch Tests, Diabetes Mellitus, Type 1, Allergens. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Stig and Ragna Gorthon Foundation, HudFonden, Svenska Diabetesstiftelsen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous studies on contact allergy to diabetes medical devices (MDs) are based on patients referred for patch testing due to suspected allergic contact dermatitis.

Objectives

To present real‐world data on contact allergy to MD allergens among diabetes MD users. To suggest a MD patch test series.

Methods

Adults with type 1 diabetes using diabetes MDs followed up at two endocrinology departments were invited to be patch tested with a novel MD patch test series.

Results

Of the 204 participants (114 with skin rash to diabetes MDs, 90 without), 16.2% were positive to allergens found in diabetes MDs. The prevalence was significantly higher in those with skin rash to diabetes MDs versus without (28.1% vs. 1.1%; adjusted p ‐value < 0.001). For allergens found in diabetes MDs, the highest contact allergy rates were seen to isobornyl acrylate (10.3%), N,N‐ dimethylacrylamide (4.9%), 2‐hydroxyethyl acrylate (3.4%), and dicyclohexylmethane‐4,4′‐diisocyanate (2.9%).

Conclusions

Among diabetes MD users, the prevalence of contact allergy to MD allergens was remarkably high. 2‐hydroxyethyl acrylate has not previously been reported as a culprit allergen in diabetes MDs, which underlines the importance of repeated chemical analyses and continuous update of the MD series. A better prevention of MD‐related contact allergies is called for.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, Allergic ContactPatch TestsDiabetes Mellitus, Type 1AllergensInsulin Infusion SystemsEquipment and SuppliesHumansFemaleMaleMiddle AgedAdultPrevalenceAgedAcrylatesCamphanes

Stichwörter der Autor:innen

contact allergycontinuous glucose monitoringinsulin infusion systemstype 1 diabetes

Substanzen

Allergensisobornyl acrylateAcrylatesCamphanes

Autor:innen und Institutionen

  • Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden.

ORCID-Profile: Josefin Ulriksdotter, Martin Mowitz, Magnus Bruze, Nils Hamnerius

Förderung

  • The Stig and Ragna Gorthon Foundation
  • HudFonden
  • Svenska Diabetesstiftelsen
  • Astma- och Allergiförbundet

Zitieren

APA

Ulriksdotter, J., Mowitz, M., Sukakul, T., Bruze, M., Hamnerius, N., & Svedman, C. (2026). Patch Testing in Individuals With Diabetes Using Medical Devices. Part 2—Contact Allergy to Medical Device Allergens and New Patch Test Recommendations. Contact Dermatitis, 95(2), 169-181. https://doi.org/10.1111/cod.70149

Vancouver

Ulriksdotter J, Mowitz M, Sukakul T, Bruze M, Hamnerius N, Svedman C. Patch Testing in Individuals With Diabetes Using Medical Devices. Part 2—Contact Allergy to Medical Device Allergens and New Patch Test Recommendations. Contact Dermatitis. 2026;95(2):169-181. doi:10.1111/cod.70149

BibTeX
@article{Ulriksdotter2026,
  author = {Ulriksdotter, Josefin and Mowitz, Martin and Sukakul, Thanisorn and Bruze, Magnus and Hamnerius, Nils and Svedman, Cecilia},
  title = {Patch Testing in Individuals With Diabetes Using Medical Devices. Part 2—Contact Allergy to Medical Device Allergens and New Patch Test Recommendations},
  journal = {Contact Dermatitis},
  year = {2026},
  volume = {95},
  number = {2},
  pages = {169--181},
  doi = {10.1111/cod.70149}
}
Kostenlos starten →